Global Health Data Exchange - Discover the World's Health Data

Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial

Nav

General Info
Geography 
Argentina (ARG)
Austria (AUT)
Belgium (BEL)
Brazil (BRA)
Canada (CAN)
China (CHN)
Denmark (DNK)
Finland (FIN)
France (FRA)
Germany (DEU)
Greece (GRC)
Hungary (HUN)
Iceland (ISL)
Indonesia (IDN)
Ireland (IRL)
Israel (ISR)
Italy (ITA)
Mexico (MEX)
Norway (NOR)
Poland (POL)
Portugal (PRT)
Russia (RUS)
Slovakia (SVK)
Spain (ESP)
Turkey (TUR)
Time period covered 
01/1997 - 12/2003
Citation
Authors 
Julius S, Kjeldsen SE, Weber M, Brunner HR, Ekman S, Hansson L, Hua T, Laragh J, McInnes GT, Mitchell L, Plat F, Schork A, Smith B, Zanchetti A, VALUE trial group
Journal 
Lancet
Volume 
363
Issue 
9426
Pages 
2022-31
Publication year 
2004
Suggested citation 
Julius S, Kjeldsen SE, Weber M, Brunner HR, Ekman S, Hansson L, Hua T, Laragh J, McInnes GT, Mitchell L, Plat F, Schork A, Smith B, Zanchetti A, VALUE trial group. Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial. Lancet. 2004; 363(9426): 2022-31.